These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30340569)

  • 61. [Interpretation and evaluation of the American Joint committee on Cancer (AJCC) 8th Edition Staging System for patients with gastroenteropancreatic neuroendocrine tumors].
    Chen L; Zhou Z; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):972-976. PubMed ID: 28900985
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Revised nodal stage for pancreatic neuroendocrine tumors.
    Luo G; Jin K; Cheng H; Guo M; Lu Y; Wang Z; Yang C; Xu J; Gao H; Zhang S; Zhang B; Long J; Xu J; Ni Q; Liu C; Yu X
    Pancreatology; 2017; 17(4):599-604. PubMed ID: 28610828
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis.
    Chen YT; Huang ZP; Zhou ZW; He MM
    Med Oncol; 2016 Nov; 33(11):122. PubMed ID: 27730526
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Neuroendocrine Neoplasia within the German NET Registry].
    ; ;
    Z Gastroenterol; 2018 Oct; 56(10):1237-1246. PubMed ID: 30304748
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile-based classification.
    Ferris LK; Farberg AS; Middlebrook B; Johnson CE; Lassen N; Oelschlager KM; Maetzold DJ; Cook RW; Rigel DS; Gerami P
    J Am Acad Dermatol; 2017 May; 76(5):818-825.e3. PubMed ID: 28110997
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [The TNM and WHO classifications of neuroendoctine neoplasia of the pancreas].
    Kochatkov AV; Zamolodchikov RD; Golubev GK
    Khirurgiia (Mosk); 2013; (10):63-71. PubMed ID: 24579104
    [No Abstract]   [Full Text] [Related]  

  • 68. Pancreatic neuroendocrine tumors: Nosography, management and treatment.
    Orditura M; Petrillo A; Ventriglia J; Diana A; Laterza MM; Fabozzi A; Savastano B; Franzese E; Conzo G; Santini L; Ciardiello F; De Vita F
    Int J Surg; 2016 Apr; 28 Suppl 1():S156-62. PubMed ID: 26708853
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Adrenocorticotropic Hormone-Producing Pancreatic Neuroendocrine Neoplasms: A Systematic Review.
    Wu Y; Xiong G; Zhang H; Wang M; Zhu F; Qin R
    Endocr Pract; 2021 Feb; 27(2):152-157. PubMed ID: 33616046
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Pancreatic neuroendocrine neoplasms: Correlation between MR features and pathological tumor grades.
    Jin F; Wang K; Qin TT; Li X; Guo F; Ma GN; Hu XH; Han P
    J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):587-595. PubMed ID: 28786064
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
    O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
    Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Distant metastases in colorectal carcinoma: A proposal for a new M1 subclassification.
    Merkel S; Weber K; Croner RS; Golcher H; Göhl J; Agaimy A; Semrau S; Siebler J; Wein A; Hohenberger W; Wittekind C
    Eur J Surg Oncol; 2016 Sep; 42(9):1337-42. PubMed ID: 27160353
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Risk and protective factors for the occurrence of sporadic pancreatic endocrine neoplasms.
    Valente R; Hayes AJ; Haugvik SP; Hedenström P; Siuka D; Korsæth E; Kämmerer D; Robinson SM; Maisonneuve P; Delle Fave G; Lindkvist B; Capurso G
    Endocr Relat Cancer; 2017 Aug; 24(8):405-414. PubMed ID: 28566532
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cytology assessment can predict survival for patients with metastatic pancreatic neuroendocrine neoplasms.
    Sigel CS; Guo H; Sigel KM; Zhang M; Rekhtman N; Lin O; Klimstra DS; Jungbluth AA; Tang LK
    Cancer Cytopathol; 2017 Mar; 125(3):188-196. PubMed ID: 28094897
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.
    Basturk O; Yang Z; Tang LH; Hruban RH; Adsay V; McCall CM; Krasinskas AM; Jang KT; Frankel WL; Balci S; Sigel C; Klimstra DS
    Am J Surg Pathol; 2015 May; 39(5):683-90. PubMed ID: 25723112
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Neuroendocrine Neoplasia of the digestive tract].
    Begum N; Anlauf M
    Ther Umsch; 2020 Nov; 77(9):449-455. PubMed ID: 33146094
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic Performance of Current Stage III Oral Cancer Patients After Curative Intent Resection: Evidence to Support a Revision of the American Joint Committee on Cancer Staging System.
    Amit M; Yen TC; Liao CT; Chaturvedi P; Agarwal JP; Kowalski LP; Kohler HF; Ebrahimi A; Clark JR; Cernea CR; Brandao SJ; Kreppel M; Zöller J; Fliss MD; Bachar G; Shpitzer T; Bolzoni VA; Patel PR; Jonnalagadda S; Robbins KT; Iyer NG; Skanthakumar T; Shah JP; Patel SG; Gil Z
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S985-91. PubMed ID: 26314876
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms.
    Fang C; Wang W; Feng X; Sun J; Zhang Y; Zeng Y; Wang J; Chen H; Cai M; Lin J; Chen M; Chen Y; Li Y; Li S; Chen J; Zhou Z
    Br J Cancer; 2017 Nov; 117(10):1544-1550. PubMed ID: 28949958
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Predictive prognostic value of local and distant recurrence of F-fluorodeoxyglucose positron emission tomography for pancreatic neuroendocrine tumors with reference to World Health Organization classifications (2004, 2010). Case series study.
    Durán HJ; Ielpo B; Díaz E; Fabra I; Caruso R; Malavé L; Cano-Valderrama O; Garcia L; Quijano Y; Vicente E
    Int J Surg; 2016 May; 29():176-82. PubMed ID: 27063856
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prognostic validity of the American Joint Committee on Cancer staging classification for midgut neuroendocrine tumors.
    Strosberg JR; Weber JM; Feldman M; Coppola D; Meredith K; Kvols LK
    J Clin Oncol; 2013 Feb; 31(4):420-5. PubMed ID: 23248248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.